Jeffrey Goldfarb
Articles RSSArticles
UPDATE 1-Private equity firms to be asked to open up
LONDON, Nov 19 (Reuters) - The private equity industry, which employs about 8 percent of Britons working in the private sector, will be asked to become more transparent to shed its image of secretiveness, a report is expected to say on Tuesday. Full Article
Private equity firms to be asked to open up
LONDON, Nov 19 (Reuters) - The private equity industry, employer of about 8 percent of Britons working in the private sector, will be asked to become more transparent to shed its image of secretiveness, a report is expected to say on Tuesday. Full Article
Romania pay-TV firm RCS & RDS pulls IPO
LONDON, Nov 6 (Reuters) - Romania-based satellite TV, phone and Internet company RCS & RDS <RCSSq.L> on Tuesday withdrew an IPO of up to $540 million, citing market conditions. Full Article
Dubai fund buys UK's Alliance Medical
LONDON (Reuters) - Dubai International Capital has bought Alliance Medical for 600 million pounds ($1.25 billion), with plans to expand one of Europe's largest MRI and CT scan services provider into the Middle East and Asia. Full Article
Mid Europa readies region's largest buyout fund
VIENNA (Reuters) - Private equity firm Mid Europa Partners is set to close a 1.5 billion euro ($2.1 billion) fund, ahead of its original goal and by far the largest devoted to the central European region, its managing partner said on Tuesday. Full Article
Pfizer, Sanofi, J&J may be among Biogen bidders
LONDON/BOSTON, Oct 15 (Reuters) - Biogen Idec Inc <BIIB.O>, which has put itself up for sale, may get bids of around $25-30 billion from several of the world's top drugmakers keen to expand in the hot area of biotech medicine. Full Article
Buyout firm slams "half-baked" UK policies
VIENNA (Reuters) - Buyout firm Mid Europa Partners said more "half-baked" policies from the British government in reaction to a political and union outcry against private equity could prompt it to leave the country. Full Article
Pfizer, Sanofi, J&J may be among Biogen bidders
LONDON/BOSTON (Reuters) - Biogen Idec Inc <BIIB.O>, which has put itself up for sale, may get bids of around $25-30 billion from several of the world's top drugmakers keen to expand in the hot area of biotech medicine. Full Article
UPDATE 1-Pfizer, Sanofi, J&J may be among Biogen bidders
LONDON/BOSTON, Oct 15 (Reuters) - Biogen Idec Inc <BIIB.O>, which has put itself up for sale, may get bids of around $25-30 billion from several of the world's top drugmakers keen to expand in the hot area of biotech medicine. Full Article
Not enough C. Europe deals for buyers: banker
VIENNA (Reuters) - Much of central and eastern Europe is no longer considered an emerging market by corporate and private equity buyers, but it will be another five years before the area sees a steady flow of bigger deals, an investment banker focused ... Full Article
